Correlation Between Edgewise Therapeutics and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Akero Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Akero Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Akero Therapeutics
0.86 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Edgewise and Akero is 0.86. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Akero Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 1.62 times more return on investment than Akero Therapeutics. However, Edgewise Therapeutics is 1.62 times more volatile than Akero Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Akero Therapeutics is currently generating about 0.09 per unit of risk. If you would invest 599.00 in Edgewise Therapeutics on August 24, 2024 and sell it today you would earn a total of 2,599 from holding Edgewise Therapeutics or generate 433.89% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Akero Therapeutics
Performance |
| Timeline |
| Edgewise Therapeutics |
| Akero Therapeutics |
Edgewise Therapeutics and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Akero Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Edgewise Therapeutics vs. ZyVersa Therapeutics | Edgewise Therapeutics vs. Sonnet Biotherapeutics Holdings | Edgewise Therapeutics vs. Zura Bio Limited | Edgewise Therapeutics vs. Phio Pharmaceuticals Corp |
| Akero Therapeutics vs. ZyVersa Therapeutics | Akero Therapeutics vs. Sonnet Biotherapeutics Holdings | Akero Therapeutics vs. Zura Bio Limited | Akero Therapeutics vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |